Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category
Continent
From
To
 
Argenx permanently grounds studies of high-flying...

Argenx permanently grounds studies of high-flying...

Category : Clinical Trial Update 16 December 2025

"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
Novo’s oral semaglutide edges out CagriSema, Lilly...

Novo’s oral semaglutide edges out CagriSema, Lilly...

Category : Product Related Updates 16 December 2025

"As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity m...
Scienture and BlinkRx Partner to Expand Access to...

Scienture and BlinkRx Partner to Expand Access to...

Category : Licensing/Collaboration Deal 13 December 2025

Scienture Holdings Inc has announced a strategic collaboration with Blink Rx to expand nationwide ac...
Novo Nordisk Launches Ozempic in India for Type 2...

Novo Nordisk Launches Ozempic in India for Type 2...

Category : Approval/Launch 13 December 2025

Novo Nordisk has officially launched Ozempic (injectable semaglutide) in India. The once-weekly ther...
Pfizer Secures Global Rights to Fosun Pharma’s Ora...

Pfizer Secures Global Rights to Fosun Pharma’s Ora...

Category : Licensing/Collaboration Deal 12 December 2025

China’s Fosun Pharma has signed a major collaboration and licensing deal with Pfizer, marking...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!